1. Home
  2. NWGL vs GDTC Comparison

NWGL vs GDTC Comparison

Compare NWGL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • GDTC
  • Stock Information
  • Founded
  • NWGL 2008
  • GDTC 2018
  • Country
  • NWGL Macau
  • GDTC Singapore
  • Employees
  • NWGL N/A
  • GDTC N/A
  • Industry
  • NWGL
  • GDTC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • GDTC Health Care
  • Exchange
  • NWGL Nasdaq
  • GDTC Nasdaq
  • Market Cap
  • NWGL 26.2M
  • GDTC 28.0M
  • IPO Year
  • NWGL 2023
  • GDTC 2023
  • Fundamental
  • Price
  • NWGL $1.02
  • GDTC $2.02
  • Analyst Decision
  • NWGL
  • GDTC Buy
  • Analyst Count
  • NWGL 0
  • GDTC 1
  • Target Price
  • NWGL N/A
  • GDTC $5.00
  • AVG Volume (30 Days)
  • NWGL 300.9K
  • GDTC 7.2K
  • Earning Date
  • NWGL 07-29-2025
  • GDTC 01-01-0001
  • Dividend Yield
  • NWGL N/A
  • GDTC N/A
  • EPS Growth
  • NWGL N/A
  • GDTC N/A
  • EPS
  • NWGL N/A
  • GDTC N/A
  • Revenue
  • NWGL $21,539,347.00
  • GDTC $368,838.00
  • Revenue This Year
  • NWGL N/A
  • GDTC $5.37
  • Revenue Next Year
  • NWGL N/A
  • GDTC N/A
  • P/E Ratio
  • NWGL N/A
  • GDTC N/A
  • Revenue Growth
  • NWGL N/A
  • GDTC N/A
  • 52 Week Low
  • NWGL $0.91
  • GDTC $1.20
  • 52 Week High
  • NWGL $6.61
  • GDTC $4.05
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 45.50
  • GDTC 40.10
  • Support Level
  • NWGL $0.99
  • GDTC $2.01
  • Resistance Level
  • NWGL $1.07
  • GDTC $2.22
  • Average True Range (ATR)
  • NWGL 0.07
  • GDTC 0.09
  • MACD
  • NWGL -0.00
  • GDTC -0.02
  • Stochastic Oscillator
  • NWGL 46.67
  • GDTC 5.88

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: